Zepp Health
ZEPP
21 hedge funds and large institutions have $5.09M invested in Zepp Health in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 0 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
17% more funds holding
Funds holding: 18 → 21 (+3)
0.04% more ownership
Funds ownership: 1.68% → 1.72% (+0.04%)
42% less capital invested
Capital invested by funds: $8.78M → $5.09M (-$3.69M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$45.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$43.2K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$24.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$20.7K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$14.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$232K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
-$1.13K |
| 3 |
JP Morgan Chase
New York
|
-$32 |
ZEPP Hedge Fund Activity: Q2 2024 in Review
21 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Zepp Health (ZEPP) for Q2 2024, worth a combined $5.09M — down 42% from $8.78M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ZEPP positions and 0 closed out — a net gain of 3 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $45.6K. The largest seller was Allspring Global Investments, cutting an estimated $232K.
- 21 institutional investors held Zepp Health (ZEPP) as of Q2 2024, up from 18 in Q1 2024.
- Funds reported $5.09M of Zepp Health stock for Q2 2024, down 42% quarter-over-quarter.
- 3 funds opened new Zepp Health positions in Q2 2024 and 0 closed out, a net change of +3 holders.
- The largest Zepp Health buyer in Q2 2024 was Morgan Stanley, an estimated $45.6K added.
- The largest Zepp Health seller in Q2 2024 was Allspring Global Investments, an estimated $232K sold.
Based on aggregated 13F filings for Q2 2024.